MYLAN 5300 MYLAN 5300 (Nizatidine 300 mg)
Pill imprint MYLAN 5300 MYLAN 5300 has been identified as Nizatidine 300 mg.
Nizatidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; indigestion; duodenal ulcer prophylaxis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Nizatidine 300 mg is classified as a Schedule N controlled substance under the Controlled Substance Act (CSA).
- 300 mg
- 17.00 mm
- Rx and/or OTC
D&C Red No. 28
FD&C Blue No. 1
FD&C Red No. 40
sodium lauryl sulfate
More about nizatidine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.